Structure and function of human tissue‐type plasminogen activator (t‐PA)
- 1 January 1986
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 32 (3) , 169-178
- https://doi.org/10.1002/jcb.240320302
Abstract
Full‐length tissue‐type plasminogen activator (t‐PA) cDNA served to construct deletion mutants within the N‐terminal “heavy” (H)‐chain of the t‐PA molecule. The H‐chain cDNA consists of an array of structural domains homologous to domains present on other plasma proteins (“finger,” “epidermal growth factor,” “kringles”). These structural domains have been located on an exon or a set of exons. The endpoints of the deletions nearly coincide with exon‐intron junctions of the chromosomal t‐PA gene. Recombinant t‐PA deletion mutant proteins were obtained after transient expression in mouse Ltk−, cells, transfected with SV40‐pBR322‐derived t‐PA cDNA plasmids. It is demonstrated that the serine protease moiety of t‐PA and its substrate specificity for plasminogen is entirely contained within the C‐terminal “light” (L)‐chain of the protein. The presence of cDNA, encoding the t‐PA signal peptide preceding the remaining portion of t‐PA, suffices to achieve secretion of (mutant) t‐PA into the medium. The stimulatory effect of fibrin on the plasminogen activator activity of t‐PA was shown to be mediated by the kringle K2 domain and, to a lesser extent, by the finger domain. The other domains on the H‐chain, kringle Kl, and the epidermal growth‐factor‐like domain, do not contribute to this property of t‐PA. These findings correlate well with the fibrin‐binding properties of the rt‐PA deletion‐mutant proteins, indicating that stimulation of the activity is based on aligning of the substrate plasminogen and its enzyme t‐PA on the fibrin matrix. The primary target for endothelial plasminogen activator inhibitor (PAI) is located within the L‐chain of t‐PA. Deleting specific segments of t‐PA H‐chain cDNA and subsequent transient expression in mouse Ltk− cells of t‐PA deletion‐mutant proteins did not affect the formation of a stable complex between mutant t‐PA and PAI.Keywords
This publication has 29 references indexed in Scilit:
- Functional analysis of the human tissue-type plasminogen activator protein: the light chainGene, 1986
- Expression in E. coli of finger‐domain lacking tissue‐type plasminogen activator with high fibrin affinityFEBS Letters, 1985
- Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modulesCell, 1985
- Functional properties of carbohydrate-depleted tissue plasminogen activatorBiochemistry, 1984
- Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned mediumBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Common evolutionary origin of the fibrin‐binding structures of fibronectin and tissue‐type plasminogen activatorFEBS Letters, 1983
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Nucleotide sequence analysis of the chloramphenicol resistance transposon Tn9Nature, 1979
- An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue cultureBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- A study of proteases and protease-inhibitor complexes in biological fluidsThe Journal of Experimental Medicine, 1978